VOYA Investment Management’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$445K	Sell	18,890 -20,994	-53%	-$536K	﹤0.01%	1771
2025 Q4	$1.16M	Buy	39,884 +20,620	+107%	+$528K	﹤0.01%	1432
2025 Q3	$363K	Sell	19,264 -10,105	-34%	-$159K	﹤0.01%	1908
2025 Q2	$412K	Buy	29,369 +313	+1%	+$4.39K	﹤0.01%	1981
2025 Q1	$454K	Sell	29,056 -3,080	-10%	-$43.4K	﹤0.01%	1908
2024 Q4	$448K	Sell	32,136 -2,472	-7%	-$27.1K	﹤0.01%	1992
2024 Q3	$322K	Sell	34,608 -806	-2%	-$7.95K	﹤0.01%	2231
2024 Q2	$329K	Buy	35,414 +9,258	+35%	+$83.7K	﹤0.01%	2212
2024 Q1	$259K	Sell	26,156 -67,056	-72%	-$500K	﹤0.01%	2329
2023 Q4	$301K	Buy	93,212 +54,930	+143%	+$149K	﹤0.01%	2344
2023 Q3	$203K	Buy	38,282 +707	+2%	+$6.01K	﹤0.01%	2534
2023 Q2	$358K	Buy	37,575 +4,944	+15%	+$54.9K	﹤0.01%	2260
2023 Q1	$359K	Sell	32,631 -2,740	-8%	-$39.6K	﹤0.01%	2229
2022 Q4	$523K	Hold	35,371	–	–	﹤0.01%	2015
2022 Q3	$676K	Buy	35,371 +22,246	+169%	+$504K	﹤0.01%	1840
2022 Q2	$280K	Buy	13,125 +2,385	+22%	+$48.9K	﹤0.01%	2214
2022 Q1	$207K	Hold	10,740	–	–	﹤0.01%	2348
2021 Q4	$223K	Sell	10,740 -39	-0.4%	-$776	﹤0.01%	2446
2021 Q3	$258K	Hold	10,779	–	–	﹤0.01%	2422
2021 Q2	$294K	Buy	10,779 +1,343	+14%	+$37.8K	﹤0.01%	2385
2021 Q1	$273K	Buy	9,436 +1,003	+12%	+$31.3K	﹤0.01%	2363
2020 Q4	$237K	Buy	+8,433	New	+$207K	﹤0.01%	2334